Cabot Corp. Stock
Price
Target price
€81.40
€81.40
1.690%
1.35
1.690%
€59.65
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cabot Corp. Stock
There is an upward development for Cabot Corp. compared to yesterday, with an increase of €1.35 (1.690%).
With 6 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
On the other hand, the target price of 59 € is below the current price of 81.4 € for Cabot Corp., so the potential is actually -27.52%.
Pros and Cons of Cabot Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cabot Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cabot Corp. | 1.690% | 2.583% | 11.202% | 25.231% | 45.357% | 37.966% | 71.008% |
| Innospec Inc. | - | 0.699% | 2.128% | 0.699% | 9.091% | -19.101% | - |
| Sensient Technologies Corp. | -1.870% | 7.143% | 3.960% | 25.749% | 31.250% | 62.791% | - |
| Stepan Co | 4.290% | 4.292% | 5.652% | 3.404% | 22.111% | -42.485% | -53.269% |
Comments
Cabot (CBT) was upgraded by Wall Street Zen from "hold" to "buy".
Show more
Ratings data for CBT provided by MarketBeat
Cabot (CBT) is now covered by Truist Financial Corporation. They set a "buy" rating and a $98.00 price target on the stock.
Show more
Ratings data for CBT provided by MarketBeat
Cabot (CBT) had its price target raised by JPMorgan Chase & Co. from $68.00 to $70.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for CBT provided by MarketBeat
News
Why a Fund Made a $3.5 Million Bet on This Flat Chemicals Stock With Declining Revenue and Earnings
On April 22, 2026, 1492 Capital Management disclosed a new position in Cabot Corporation (NYSE:CBT), acquiring 48,057 shares in the first quarter. The estimated transaction value was $3.49 million
